Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × spartalizumab × Clear all

NCT06758037 2025-03-18

HiR+X

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT03365791 2022-05-27

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Phase 2 Completed

76 enrolled 14 charts

GastrointestinalLymphoidSarcomaThoracic

Adenocarcinoma Of Esophagus, Lymphoma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Small Cell Lung Carcinoma